Skip to content

Clinical trials

Neoplasm Metastasis trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Country / region: United Kingdom Clear all

307 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20025
20035
20047
20059
200612
200712
20088
200913
201010
201113
201216
201313
201416
201514
201616
201714
201810
201914
202012
202121
202219
20239
202413
202512
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed150
Terminated48
Active, not recruiting43
Recruiting41
Unknown status21
Suspended2
Approved for marketing1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca29
Novartis Pharmaceuticals15
Eli Lilly and Company13
European Organisation for Research and Treatment of Cancer - EORTC10
Pfizer8
Sanofi8
Royal Marsden NHS Foundation Trust7
Bayer6
Daiichi Sankyo6
Astellas Pharma Inc5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis307
Breast Neoplasms63
Neoplasms61
Carcinoma, Non-Small-Cell Lung41
Colorectal Neoplasms36
Prostatic Neoplasms29
Melanoma22
Ovarian Neoplasms18
Carcinoma, Renal Cell15
Recurrence15

Trials

Showing 1 to 25 of 307. Each trial links to its page on Pharma Observatory.

207 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.